Development of aldose reductase inhibitors for the treatment of inflammatory disorders.
about
Zolfino landrace (Phaseolus vulgaris L.) from Pratomagno: general and specific features of a functional foodDiverse Molecular Targets for Chalcones with Varied Bioactivities.Chalcone: A Privileged Structure in Medicinal Chemistry.Aldose reductase interacts with AKT1 to augment hepatic AKT/mTOR signaling and promote hepatocarcinogenesis.Phytochemical analysis with the antioxidant and aldose reductase inhibitory capacities of Tephrosia humilis aerial parts' extracts.Novel quinazolinone-based 2,4-thiazolidinedione-3-acetic acid derivatives as potent aldose reductase inhibitors.2-Chloro-1,4-naphthoquinone derivative of quercetin as an inhibitor of aldose reductase and anti-inflammatory agent.
P2860
Q37094529-8F15F855-13C9-4765-8F8C-7C02FDE958B8Q38707609-95B072D3-8AB6-4348-BAF1-882F47873855Q39295083-63145940-49AB-4432-862C-2E0AC18BBD3DQ42366521-C6097AD8-3667-41B6-85AA-8D388C0E8E74Q47392687-75996448-A154-40B9-AB64-6ED97CB82D83Q47446145-F4A0F377-7F0E-4D66-AEAB-C1B8B6DDA6C7Q50475900-18471CE7-8A43-44ED-90AE-072A328543FB
P2860
Development of aldose reductase inhibitors for the treatment of inflammatory disorders.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Development of aldose reductase inhibitors for the treatment of inflammatory disorders.
@en
type
label
Development of aldose reductase inhibitors for the treatment of inflammatory disorders.
@en
prefLabel
Development of aldose reductase inhibitors for the treatment of inflammatory disorders.
@en
P2860
P1476
Development of aldose reductase inhibitors for the treatment of inflammatory disorders.
@en
P2093
Kyriaki Pegklidou
Nikolaos Papastavrou
P2860
P304
P356
10.1517/17460441.2013.843524
P407
P577
2013-10-03T00:00:00Z